IMPACT Therapeutics’ Senaparib Receives Positive EMA CHMP Opinion for Ovarian Cancer Maintenance Treatment IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on developing targeted anti-cancer therapies based on synthetic lethality…
Largest Lung Cancer MRD Study Demonstrates Signatera™’s Strong Prognostic Value Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and precision medicine, has announced new clinical data presented…
LEO Pharma Gains FDA Priority Review for Dersimelagon NDA Following Acquisition of Global Rights LEO Pharma, a global leader in medical dermatology, has announced two significant developments for dersimelagon, an…
MaaT Pharma Reports CHMP Maintains Negative Opinion on MaaT013 for Acute Graft-versus-Host Disease MaaT Pharma (Euronext: MAAT), a clinical-stage biotechnology company developing Microbiome Ecosystem Therapies™ (MET) designed to modulate the…
Sensorion to Host SENS-601 Program Day on GJB2-Related Hearing Loss Gene Therapy Sensorion (FR001401A9Z0 – ALSEN), a clinical-stage biotechnology company focused on developing novel therapies designed to restore, treat, and…
Takeda Awards $22.2 Million to Four Global CSR Partners to Strengthen Climate-Resilient Health Systems Takeda (TSE: 4502/NYSE: TAK) has announced a total commitment of $22.2 million to four new Global…
PAHO-Gilead HIV Prevention Deal in Latin America Welcomed by AHF as Civil Society Victory AIDS Healthcare Foundation (AHF), one of the world’s largest HIV/AIDS healthcare organizations, has welcomed a new…
Puma Biotechnology Initiates Phase II ALISCA®-Lung2 Trial of Alisertib and Paclitaxel in Advanced Small Cell Lung Cancer Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company focused on developing innovative cancer…
Faeth Therapeutics Appoints Cancer Biology Expert Karen Vousden, Ph.D., to Board of Directors Faeth Therapeutics, Inc. (Nasdaq: FTH), a clinical-stage biotechnology company developing therapies designed to improve outcomes for cancer…
AptarGroup and MGH’s Alice Stanton Launch Research Collaboration to Advance Nose-to-Brain Drug Delivery AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies and consumer product…
Guardant Health’s Shield Blood Test Gains EviCore Coverage, Expanding Access to Colorectal Cancer Screening Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that its Shield™ blood test…
Paradromics Connexus BCI Enables First Participant to Communicate in Real Time Using Neural Signals Paradromics Inc., a neurotechnology company developing a high-data-rate brain-computer interface (BCI) platform aimed at restoring and…